← Eichor
Study identifier: NCT05686525 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Clinical Trial on the Effectiveness of TUMT Compared to PAE in Reducing Severe LUTS in Men with BPH

Condition: Prostatic Hyperplasia · Lower Urinary Tract Symptoms  ·  Sponsor: Rigshospitalet, Denmark

PhaseNA
Planned participants220
Who can joinMale, 40 Years to no upper limit
Healthy volunteersNo

About this study

The TUMT-PAE-1 trial is a randomised clinical trial aiming to compare the effectiveness of transurethral microwave thermotherapy (TUMT) with prostatic artery embolisation (PAE) in reducing urinary symptoms caused by prostate gland enlargement. The assessment will be done by patient reported and functional outcome measures. The primary purpose is to evaluate the urinary symptoms six months after the procedure, measured by the International Prostate Symptom Score (IPSS).

This description comes directly from the study's public registry record.

Talk to the study team

Anna Kristensen-Alvarez, MD  ·  +4535456152  ·  anna.kristensen-alvarez@regionh.dk

Always discuss trial participation with your own doctor first.

Locations (3)

Urological Research Unit, RigshospitaletCopenhagen, Copenhagen N, DenmarkRecruiting
Department of Urology, Herlev-Gentofte HospitalGentofte Municipality, Hellerup, DenmarkRecruiting
Zealand University HospitalRoskilde, DenmarkRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05686525